3593 On Other Exchanges
Symbol
Exchange
3593 is not on other exchanges.

hogy medical co ltd (3593) Snapshot

Open
--
Previous Close
--
Day High
--
Day Low
--
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
--
Average Volume 10 Days
--
EPS TTM
--
Shares Outstanding
--
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for HOGY MEDICAL CO LTD (3593)
\

Related News

No related news articles were found.

hogy medical co ltd (3593) Related Businessweek News

No Related Businessweek News Found

hogy medical co ltd (3593) Details

Hogy Medical Co.,Ltd. develops and supplies various medical products for healthcare facilities in Japan and internationally. The company offers kit products for surgery applications; and non-woven products, including gowns, caps, underwear, drapes, packaged products, equipment covers, kurumu, towels, isolation gowns, caps, masks, and accessories for use in operating rooms, outpatient areas, hospital wards, and other areas, as well as Tigalyer, a multi-layer fabric. It also provides sterilization products, such as hybrid Mekkin bags, hybrid Mekkin bags ID layered type, and autoclave forceps stand caps; Mekkin cards, which are detection cards used to judge the sterilization process when sterilizing in an autoclave; ethylene oxide gas cards that are detection cards used to judge the sterilization process when sterilizing using ethylene oxide gas; and indicator tapes for autoclave sterilization. In addition, the company offers IC Tracer, a gauze control system that uses integrated circuit chips embedded in each gauze used during surgery, making each one traceable; ASRC, a product made of a foamed polyethylene sponge that provides flexibility and functionality for use in varying procedures and inosculations; and Securea, a polyurethane sponge for endoscopic surgery. The company was formerly known as Hogy Co., Ltd. and changed its name to Hogy Medical Co.,Ltd. in 1987. Hogy Medical Co.,Ltd. was founded in 1955 and is headquartered in Tokyo, Japan.

Founded in 1955

hogy medical co ltd (3593) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

hogy medical co ltd
Hogy Medical Co. Ltd. Announces Consolidated and Non-Consolidated Earnings Results for the Year Ended March 31, 2018; Provides Consolidated and Non-Consolidated Earnings Guidance for the First Two Quarters and Fiscal Year Ending March 31, 2019

Hogy Medical Co. Ltd. announced consolidated and non-consolidated earnings results for the year ended March 31, 2018. For the year, the company reported consolidated net sales of JPY 36,918 million compared to JPY 36,859 million a year ago. Operating income was JPY 5,273 million compared to JPY 7,443 million a year ago. Ordinary income was JPY 5,380 million compared to JPY 7,403 million a year ago. Income before income taxes was JPY 7,583 million compared to JPY 8,422 million a year ago. Profit attributable to owners of parent of JPY 5,262 million compared to JPY 5,786 million a year ago. Profit per share of JPY 168.04 compared to JPY 184.53 a year ago. Net cash provided by operating activities was JPY 8,367 million compared to JPY 10,066 million a year ago. Purchase of tangible fixed assets was JPY 3,675 million compared to JPY 5,308 million a year ago. Purchase of intangible fixed assets was JPY 402 million compared to JPY 535 million a year ago. ROE was 5.7% against 6.5% a year ago. For the year, the company reported non-consolidated total net sales of JPY 36,585 million compared to JPY 36,557 million a year ago. Operating income was JPY 4,338 million compared to JPY 6,447 million a year ago. Ordinary income was JPY 4,618 million compared to JPY 6,730 million a year ago. Net income was JPY 4,736 million compared to JPY 5,419 million a year ago. Profit per share of JPY 151.24 compared to JPY 172.84 a year ago. Income before income taxes was JPY 6,818 million compared to JPY 7,748 million a year ago. The company provided consolidated and non-consolidated earnings guidance for the first two quarters and fiscal year ending March 31, 2019. For the year, the company expects net sales of JPY 38,770 million, operating income of JPY 5,920 million, ordinary income of JPY 6,050 million, profit attributable to owners of parent of JPY 5,450 million and profit per share of JPY 173.97. For the first two quarters of fiscal year ending March 31, 2019, the company expects consolidated net sales of JPY 19,130 million, operating income of JPY 2,860 million, ordinary income of JPY 2,950 million, profit attributable to owners of parent of JPY 2,080 million and profit per share of JPY 66.40. The company provided non-consolidated earnings guidance for the fiscal year ending March 31, 2019. For the year, the company expects net sales of JPY 38,350 million, operating income of JPY 4,980 million, ordinary income of JPY 5,280 million, profit attributable to owners of parent of JPY 4,920 million and profit per share of JPY 157.05. For the first two quarters of fiscal year ending March 31, 2018, the company expects non-consolidated net sales of JPY 18,930 million, operating income of JPY 2,370 million, ordinary income of JPY 2,430 million, profit attributable to owners of parent of JPY 1,690 million and profit per share of JPY 53.95.

Mitsubishi Corporation and Hogy Medical Company Limited Form Comprehensive Alliance

Hogy Medical Company Limited and Mitsubishi Corporation announced that they have entered into a comprehensive business alliance in the medical business field. The domestic business environment poses a severe challenge for hospitals in Japan in light of the country’s aging population and rising medical costs. Meanwhile, overseas markets where demand for new medical services continues to increase show tremendous potential for growth. While Hogy Medical has been developing products that contribute to the safety of patients and healthcare staff and to the improvement of hospital management since its establishment in 1961, MC has built up an extensive network, both domestically and abroad, over many years and has amassed a wealth of experience engaging with diverse sectors in overseas markets. Given that backdrop, both partners felt that there is much to gain in terms of mutual benefit should they pool the knowledge and individual strengths that they have cultivated to develop a new medical consumables and services business. The alliance will focus on the following three areas as both companies seek to meet changing demands. Developing Business for Medical Consumables in Overseas Markets. Expand and open up new markets for Hogy brand products, including potentially establishing a joint venture; identify companies from which to procure kit products; and create alliances with medical consumables manufacturers for the purpose of manufacturing new products. Establishing Business for Reprocessing of Single Use Devices (SUD) Explore the possibilities for establishing SUD reprocessing business in the areas of manufacturing, distribution, collection, and sales, in light of projections that the demand for SUD reprocessing is expected to increase in Japan due to its cost advantage and effective resource utilization as well as its positive impact on environmental conservation. SUD Reprocessing refers to the collection, testing, disassembling, decontamination, and sterilization of used Single Use Devices (SUD) and reprocessing them into SUDs that can be resold for the same purpose as their original use. Japan’s Ministry of Health established new regulations for the reprocessing business on July 31, 2017. Developing Next Generation Management Support Solutions for Acute Care Hospitals Draw on the customer base and know-how established and cultivated by both companies to develop new generation management support solutions that will contribute to improving the management of the whole supply chain at acute care hospitals.

Hogy Medical Co.,Ltd. to Report Fiscal Year 2018 Results on Apr 11, 2018

Hogy Medical Co.,Ltd. announced that they will report fiscal year 2018 results on Apr 11, 2018

 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

3593 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 3593.
View Industry Companies
 

Industry Analysis

3593

Industry Average

Valuation 3593 Industry Range
Price/Earnings 27.1x
Price/Sales 3.9x
Price/Book 1.5x
Price/Cash Flow 28.3x
TEV/Sales 3.4x
 | 

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact HOGY MEDICAL CO LTD, please visit www.hogy.co.jp. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.